FORTE BIOSCIENCES, INC. (FBRX) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -90.00M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-90.00M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $-76.97M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $-70.66M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $-53.44M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $-43.68M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $-44.92M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $-36.60M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $-35.63M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $-37.22M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $-33.44M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-32.49M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $-31.04M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-24.25M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $-18.24M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-13.90M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $-12.26M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $-16.53M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $-19.26M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-21.49M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $-22.68M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $-19.99M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $-49.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-46.28M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $-100.80M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $-96.48M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $-53.34M | (m) | (m) | $36.01M | (m) | (m) |
| 2019-12-31 | $-61.51M | $36.00K | (m) | $45.30M | (m) | -170863.89% |
| 2019-09-30 | $-69.92M | $36.00K | (m) | $53.32M | (m) | -194213.89% |
| 2019-06-30 | $-51.37M | $18.04M | (m) | $52.29M | (m) | -284.80% |
| 2019-03-31 | $-49.88M | $18.04M | (m) | $53.08M | (m) | -276.55% |
| 2018-12-31 | $-45.85M | $18.04M | (m) | $51.08M | (m) | -254.23% |
| 2018-09-30 | $-37.43M | (m) | (m) | $43.76M | (m) | (m) |
| 2018-06-30 | $-48.60M | (m) | (m) | $39.06M | (m) | (m) |
| 2018-03-31 | $-41.92M | (m) | (m) | $32.92M | (m) | (m) |
| 2017-12-31 | $-37.63M | (m) | (m) | $29.11M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-31.69M | (m) | (m) | $27.22M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-22.95M | (m) | (m) | $19.17M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.